Home › Melanoma › Oklahoma › Tulsa
Melanoma clinical trials in Tulsa, OK
5 studies for Melanoma are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
BostonGene and Exigent Genomic INsight Study
RecruitingObservational study
- Oklahoma Cancer Specialists and Research Institute, Tulsa
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecruitingPhase 3
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Pan-tumor MRD Study
RecruitingObservational study
- Oklahoma Cancer Specialists and Research Institute (OCSRI), Tulsa
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Saint Francis Children's Hospital, Tulsa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Tulsa
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX61 studies
- New York City, NY41 studies
- Nashville, TN34 studies
- Los Angeles, CA34 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- St. Louis, MO23 studies
- Durham, NC22 studies
- Philadelphia, PA22 studies
- Tampa, FL21 studies
- Columbus, OH21 studies
- Dallas, TX21 studies
Other studies in Tulsa
- Heart Failure13 studies
- Overweight6 studies
- COPD5 studies
- Ischemic Stroke5 studies
- Obesity5 studies
- Cardiovascular Disease5 studies
- Parkinson's Disease4 studies
- Ovarian Cancer4 studies
- Aortic Valve Stenosis4 studies
- Heart Diseases4 studies
- Cervical Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.